Argatroban

Therapeutic indications

Argatroban is indicated for:

Indication

Population group: both men and women, only adults (18 years old or older)

Percutaneous transluminal coronary angioplasty

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Intravenous

Treatment 2: Intravenous

Indication

Population group: both men and women, only adults (18 years old or older)

Argatroban is indicated for anticoagulation in adult patients with heparin-induced thrombocytopenia type II who require parenteral antithrombotic therapy. The diagnosis should be confirmed by the HIPAA (heparin induced platelet activation assay) or an equivalent test. However, such confirmation must not delay the start of treatment. 1

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Intravenous

Contraindications

Argatroban is contraindicated in the following cases:

Uncontrolled bleeding

Bleeding

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

Related medicines